KDOQI (Kidney Disease Outcomes Quality Initiative)
NKF KDOQI GUIDELINES

Executive Summaries | Anemia | Hemodialysis | Peritoneal Dialysis |
Vascular Access | Nutrition | CKD 2002 | Dyslipidemias | Bone Metabolism | Hypertension and Antihypertensive Agents | Cardiovascular Disease in Dialysis Patients | History of KDOQI | Pediatric Bone | Anemia 2006 |
Updates 2006

Clinical Practice Guidelines and Clinical Practice Recommendations
2006 Updates
Hemodialysis Adequacy
Peritoneal Dialysis Adequacy
Vascular Access


I.  CLINICAL PRACTICE GUIDELINES FOR HEMODIALYSIS ADEQUACY

Acronyms and Abbreviations

β
Standardized coefficient
β2M
β2-microglobulin
AAMI
Association for the Advancement of Medical Instrumentation
ACE
Angiotensin-converting enzyme
ADMA
Asymmetric dimethylarginine
AR
Access recirculation
ARB
Angiotensin receptor blocker
AV
Arteriovenous
BMI
Body mass index
BSA
Body surface area
BUN
Blood urea nitrogen
BW
Body weight
C
Concentration
C0/C
Predialysis to postdialysis concentration ratio
CANUSA
Canada-USA Study
CAPD
Continuous ambulatory peritoneal dialysis
CAPR
Cardiopulmonary recirculation
Cav
Average concentration
CFU
Colony-forming unit
CI
Confidence interval
CKD
Chronic kidney disease
CMS
Centers for Medicare and Medicaid Services
COX-2
Cyclooxygenase-2
CPG
Clinical Practice Guideline
CPR
Clinical Practice Recommendation
CQI
Continuous quality improvement
CVD
Cardiovascular disease
DOPPS
Dialysis Outcomes and Practice Patterns Study
DOQI
Dialysis Outcomes Quality Initiative
eKt/V
Urea-equilibrated Kt/V
ECF
Extracellular fluid
ECV
Extracellular volume
EKR
Equivalent renal clearance
G
Urea generation rate
GFR
Glomerular filtration rate
HbA1c
Hemoglobin A1c
HD
Hemodialysis
HEMO Study
Kidney Disease Clinical Studies Initiative Hemodialysis Study
HMG
3-Hydroxy-3-methylglutaryl
HR
Hazard ratio
HRQOL
Health-related quality of life
IDEAL
Initiating Dialysis Early And Late
JNC
Joint National Committee
Kce
Continuous equivalent clearance
Kd
Dialyzer clearance
KDOQI
Kidney Disease Outcomes Quality Initiative
KDQOL-SF™
Kidney Disease and Quality of Life Short Form
Kecn
Dialyzer clearance estimated by conductivity
KLS
Kidney Learning System
K0A
Dialyzer mass transfer area coefficient
Kr
Residual native kidney urea clearance
KRT
Kidney replacement therapy
Kt/V
Clearance expressed as a fraction of urea or body water volume
Kt/Vurea
Urea clearance expressed as Kt/V
Kuf
Ultrafiltration coefficient
Kurea
Effective (delivered) dialyzer urea clearance
LVH
Left ventricular hypertrophy
MDRD
Modification of Diet in Renal Disease
NCDS
National Cooperative Dialysis Study
nd
No data reported
nEKR
Equivalent renal clearance normalized to body size
NIH
National Institutes of Health
NIVM
Noninvasive monitoring
NKF
National Kidney Foundation
nPCR
Normalized protein catabolic rate
nPNA
Normalized protein nitrogen appearance rate
NS
Not significant
OR
Odds ratio
PD
Peritoneal dialysis
p38MAPK
p38 mitogen-activated protein kinase
QOL
Quality of life
rKt/V
Residual Kt/V
RC
Remote compartment
RCT
Randomized controlled trial
RKF
Residual kidney function
RR
Relative risk
SD
Standard deviation
spKt/V
Single-pool delivered Kt/V (by dialysis only, exclusive of RKF)
stdKt/V
Standard Kt/V
SRI
Solute removal index
t
Treatment time
td
Time from beginning to end of dialysis
TAC
Time-averaged concentration
TCV
Total cell volume
TMP
Transmembrane pressure
UFR
Ultrafiltration rate
URR
Urea reduction ratio
USRDS
United States Renal Data System
V
Volume, usually of body urea distribution or total body water
Vurea
Patient's volume of urea distribution